These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 16386986)

  • 21. Clinical factors related to the aqueous levels of vascular endothelial growth factor and hepatocyte growth factor in proliferative diabetic retinopathy.
    Shinoda K; Ishida S; Kawashima S; Wakabayashi T; Uchita M; Matsuzaki T; Takayama M; Shinmura K; Yamada M
    Curr Eye Res; 2000 Aug; 21(2):655-61. PubMed ID: 11148602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of a systemic angiotensin receptor blocker on vascular endothelial growth factor in the vitreous of patients with proliferative diabetic retinopathy.
    Byon IS; Jeon HS; Kim HW; Lee SJ; Lee JE; Oum BS
    Curr Eye Res; 2013 Jul; 38(7):774-80. PubMed ID: 23725216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitreous levels of stromal cell-derived factor 1 and vascular endothelial growth factor in patients with retinopathy of prematurity.
    Sonmez K; Drenser KA; Capone A; Trese MT
    Ophthalmology; 2008 Jun; 115(6):1065-1070.e1. PubMed ID: 18031819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship among VEGF, VEGF receptor, AGEs, and macrophages in proliferative diabetic retinopathy.
    Kakehashi A; Inoda S; Mameuda C; Kuroki M; Jono T; Nagai R; Horiuchi S; Kawakami M; Kanazawa Y
    Diabetes Res Clin Pract; 2008 Mar; 79(3):438-45. PubMed ID: 18053608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy.
    Funatsu H; Yamashita H; Nakanishi Y; Hori S
    Br J Ophthalmol; 2002 Mar; 86(3):311-5. PubMed ID: 11864890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema.
    Funatsu H; Yamashita H; Ikeda T; Mimura T; Eguchi S; Hori S
    Ophthalmology; 2003 Sep; 110(9):1690-6. PubMed ID: 13129863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CORRELATION OF INCREASED INTRAVITREOUS WNT3A WITH VASCULAR ENDOTHELIAL GROWTH FACTOR IN PROLIFERATIVE DIABETIC RETINOPATHY.
    Gao X; Ma K; Lu N; Hong T; Xu Y; Peng X
    Retina; 2016 Apr; 36(4):812-8. PubMed ID: 26418446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lysyl oxidase activity in the ocular tissues and the role of LOX in proliferative diabetic retinopathy and rhegmatogenous retinal detachment.
    Coral K; Angayarkanni N; Madhavan J; Bharathselvi M; Ramakrishnan S; Nandi K; Rishi P; Kasinathan N; Krishnakumar S
    Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4746-52. PubMed ID: 18566459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The activated form of gelatinase B/matrix metalloproteinase-9 is associated with diabetic vitreous hemorrhage.
    Descamps FJ; Martens E; Kangave D; Struyf S; Geboes K; Van Damme J; Opdenakker G; Abu El-Asrar AM
    Exp Eye Res; 2006 Aug; 83(2):401-7. PubMed ID: 16643893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Vitreous levels of stromal cell-derived factor-1 and vascular endothelial growth factor in diabetic retinopathy].
    Chen L; Lü L; Li Y; Huang X; Zhang J; Li S
    Yan Ke Xue Bao; 2008 Mar; 24(1):6-8. PubMed ID: 18709948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitreous levels of vascular endothelial growth factor and intercellular adhesion molecule 1 are related to diabetic macular edema.
    Funatsu H; Yamashita H; Sakata K; Noma H; Mimura T; Suzuki M; Eguchi S; Hori S
    Ophthalmology; 2005 May; 112(5):806-16. PubMed ID: 15878060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of intravitreal inflammatory cytokines and angiogenic factors in proliferative diabetic retinopathy.
    Zhou J; Wang S; Xia X
    Curr Eye Res; 2012 May; 37(5):416-20. PubMed ID: 22409294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiangiogenic shift in vitreous after vitrectomy in patients with proliferative diabetic retinopathy.
    Yoshida S; Nakama T; Ishikawa K; Arima M; Tachibana T; Nakao S; Sassa Y; Yasuda M; Enaida H; Oshima Y; Kono T; Ishibashi T
    Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):6997-7003. PubMed ID: 22977138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased vitreous levels of hydroimidazolone in type 2 diabetes patients are associated with retinopathy: a case-control study.
    Fosmark DS; Bragadóttir R; Stene-Johansen I; Berg JP; Berg TJ; Lund T; Sandvik L; Hanssen KF
    Acta Ophthalmol Scand; 2007 Sep; 85(6):618-22. PubMed ID: 17488318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ang-2 upregulation correlates with increased levels of MMP-9, VEGF, EPO and TGFβ1 in diabetic eyes undergoing vitrectomy.
    Loukovaara S; Robciuc A; Holopainen JM; Lehti K; Pessi T; Liinamaa J; Kukkonen KT; Jauhiainen M; Koli K; Keski-Oja J; Immonen I
    Acta Ophthalmol; 2013 Sep; 91(6):531-9. PubMed ID: 23106921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy.
    Deng J; Wu DZ; Gao R
    Yan Ke Xue Bao; 1999 Mar; 15(1):17-21. PubMed ID: 12579655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitreous levels of soluble vascular endothelial growth factor receptor (VEGFR)-1 in eyes with vitreoretinal diseases.
    Asato R; Kita T; Kawahara S; Arita R; Mochizuki Y; Aiello LP; Ishibashi T
    Br J Ophthalmol; 2011 Dec; 95(12):1745-8. PubMed ID: 21719570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
    Rollin R; Mediero A; Martínez-Montero JC; Roldán-Pallarés M; Suárez-Leoz M; Vidal-Fernández P; Cortés-Valdés C; Fernández-Cruz A; Fernández-Durango R
    Mol Vis; 2004 Jul; 10():450-7. PubMed ID: 15273657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Upregulation of RAGE and its ligands in proliferative retinal disease.
    Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
    Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vitreous levels of interleukin-6 and vascular endothelial growth factor in macular edema with central retinal vein occlusion.
    Noma H; Funatsu H; Mimura T; Harino S; Hori S
    Ophthalmology; 2009 Jan; 116(1):87-93. PubMed ID: 19118700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.